ホーム
探索
nav.journalClub
トレンド
その他
synapse
⌘+K
言語
日本語
日本語
Artificial intelligence and multi-omics convergence in breast cancer: Revolutionizing diagnosis, prognostication, and precision oncology | Synapse
March 3, 2026
Artificial intelligence and multi-omics convergence in breast cancer: Revolutionizing diagnosis, prognostication, and precision oncology
BJ
Bitao Jiang
University of Nottingham Ningbo China
YW
Yuefei Wu
XC
Xiao Chen
See all
Key Points
AI integration enhances the accuracy of breast cancer diagnosis, supporting more personalized treatment plans.
Multi-omics approaches analyze genetic, proteomic, and metabolomic data to refine prognostication in breast cancer.
Assessment through advanced algorithms demonstrates a significant increase in predictive capabilities for patient outcomes.
Implementing these technologies may revolutionize precision oncology strategies for effective breast cancer therapies.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Jiang et al. (Thu,) studied this question.
synapsesocial.com/papers/69a75de2c6e9836116a282b9
https://doi.org/https://doi.org/10.1016/j.critrevonc.2026.105160